Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 1 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 26 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
ERC Pharma from Gembloux, company number BE1002131150, closed financial year 2024 with a result of € -151,962 after tax. For that financial year ERC Pharma recorded a gross margin of € -49,253 and equity of € -51,962. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2025.
€ -51,962
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -151,962
Profit after tax over the fiscal year.
€ 36
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -151,962.
Debts at end 2024
€ 2.2 million
€ 198,111 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 1,091
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to ERC Pharma?
What happened at ERC Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: loss of € 151,962. filed late Source: NBB ↗
- New establishment in Gembloux. KBO
- Start of the company according to the CBE. KBO
A new publication or filing at ERC Pharma? We notify you, reason included.
Follow ERC PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Rue Jean Sonet,Isnes 10
5032 Gembloux
Rue Jean Sonet,Isnes 10 box 3
5032 Gembloux
Active since 1 January 2024
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1002.131.150
- VAT number
- BE 1002.131.150
- Registered office
- Rue Jean Sonet,Isnes 10, 5032 Gembloux
- Names & denominations
- ERC Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 9 November 2023
- Peppol
- Active · Active since 1 Jan 2001
- Contact
- [email protected] +3281728610
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Detailhandel in farmaceutische producten